The role of Pin1 in the development and treatment of cancer

被引:0
|
作者
Sang-Hyun Min
Xiao Zhen Zhou
Kun Ping Lu
机构
[1] DGMIF,New Drug Development Center
[2] Harvard Medical School,Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Center for Life Science, Beth Israel Deaconess Medical Center
[3] Fujian Medical University,Institute for Translational Medicine
来源
关键词
Proline-directed phosphorylation; Cancer-driving pathways; Tumorigenesis; Pin1; Pin1 inhibitor; Prolyl isomerase;
D O I
暂无
中图分类号
学科分类号
摘要
Protein phosphorylation and post-phosphorylation events regulate many cellular signaling pathways. Peptidyl-prolyl isomerase (Pin1) is the only peptidyl-prolyl cis/trans isomerase that interacts with numerous oncogenic or tumor suppressive phosphorylated proteins, causes conformational changes in target proteins, and eventually regulates the activities of such proteins. These alterations in activity play a pivotal role in tumorigenesis. Since Pin1 is overexpressed and/or activated in various types of cancers, and the dysregulation of proline-directed phosphorylation contributes to tumorigenesis, Pin1 represents an attractive target for cancer therapy. This review will describe the role of Pin1 in cancer and the current status of Pin1 inhibitor development.
引用
收藏
页码:1609 / 1620
页数:11
相关论文
共 50 条
  • [41] Pin1 in neuronal apoptosis
    Becker, Esther B. E.
    Bonni, Azad
    CELL CYCLE, 2007, 6 (11) : 1332 - 1335
  • [42] Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
    Wulf, G
    Garg, P
    Liou, YC
    Iglehart, D
    Lu, KP
    EMBO JOURNAL, 2004, 23 (16): : 3397 - 3407
  • [43] The prolyl isomerase PIN1 plays a critical role in fibroblast plasticity to impact pancreatic cancer
    Langer, Ellen M.
    English, Isabel A.
    Kresse, Kayleigh M.
    MacPherson, Kevin
    Allen-Petersen, Brittany L.
    Daniel, Colin J.
    Adey, Andrew
    Sears, Rosalie C.
    CANCER RESEARCH, 2021, 81 (05)
  • [44] Association of polymorphisms in PIN1 with progression and susceptibility in gastric cancer
    Huang, Li
    Luo, Ruixian
    Yang, Ziji
    Xu, Juanjuan
    Li, Hailan
    Mo, Zhuning
    FUTURE ONCOLOGY, 2022, 18 (13) : 1557 - 1568
  • [45] Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
    Nakatsu, Yusuke
    Yamamotoya, Takeshi
    Ueda, Koji
    Ono, Hiraku
    Inoue, Masa-Ki
    Matsunaga, Yasuka
    Kushiyama, Akifumi
    Sakoda, Hideyuki
    Fujishiro, Midori
    Matsubara, Akio
    Asano, Tomoichiro
    CANCER LETTERS, 2020, 470 : 106 - 114
  • [46] Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
    Yang Chen
    Ya-ran Wu
    Hong-ying Yang
    Xin-zhe Li
    Meng-meng Jie
    Chang-jiang Hu
    Yu-yun Wu
    Shi-ming Yang
    Ying-bin Yang
    Cell Death & Disease, 9
  • [47] Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy
    Chuang, Hsiang-Hao
    Zhen, Yen-Yi
    Tsai, Yu-Chen
    Chuang, Cheng-Hao
    Huang, Ming-Shyan
    Hsiao, Michael
    Yang, Chih-Jen
    BIOMEDICINES, 2021, 9 (04)
  • [48] Pin1 is Overexpressed and Correlates with Poor Prognosis in Gastric Cancer
    Min Shi
    Lingxiang Chen
    Jun Ji
    Qu Cai
    Yingyan Yu
    Bingya Liu
    Zhenggang Zhu
    Jun Zhang
    Cell Biochemistry and Biophysics, 2015, 71 : 857 - 864
  • [49] Pin1 expression contributes to lung cancer Prognosis and carcinogenesis
    Tan, Xiaogang
    Zhou, Fang
    Wan, Junting
    Hang, Jie
    Chen, Zhaoli
    Li, Baozhong
    Zhang, Cuiyan
    Shao, Kang
    Jiang, Peng
    Shi, Susheng
    Feng, Xiaoli
    Lv, Ning
    Wang, Zhen
    Ling, Yun
    Zhao, Xiaohong
    Ding, Dapeng
    Sun, Jian
    Xiong, Meihua
    He, Jie
    CANCER BIOLOGY & THERAPY, 2010, 9 (02) : 111 - 119
  • [50] The kingdom of the prolyl-isomerase Pin1: The structural and functional convergence and divergence of Pin1
    Lee, Yew Mun
    Teoh, Deryn En-Jie
    Yeung, Kay
    Liou, Yih-Cherng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10